Imara Announces FDA Clearance of Investigational New Drug Application (IND) for Tovinontrine (IMR-687) for Heart Failure with Preserved Ejection Fraction (HFpEF)
25 janv. 2022 07h00 HE
|
Imara, Inc.
Expanding patient base and potential of Imara’s small molecule oral inhibitor of phosphodiesterase-9 (PDE9) alongside hemoglobin disorders Phase 2 trial aims to select HFpEF patients with enriched...
Global Congestive Heart Failure (CHF) Market Epidemiology Guide 2021
06 déc. 2021 04h33 HE
|
Research and Markets
Dublin, Dec. 06, 2021 (GLOBE NEWSWIRE) -- The "Congestive Heart Failure (CHF) - Market Insights, Epidemiology and Market Forecast - 2030" report has been added to ResearchAndMarkets.com's...